Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· GlowUp Health

Senolytics Explained. The Science Behind Clearing Zombie Cells

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

Senescent cells are sometimes referred to as “zombie cells” because they stop dividing but remain active in the body. These cells can release inflammatory signals that affect nearby tissues and may contribute to processes associated with aging. Researchers are studying compounds called senolytics that may help target senescent cells and support cellular health. Early laboratory studies have explored how reducing senescent cell accumulation may influence tissue function and biological aging markers. This video explains the science behind senescence, why scientists are studying senolytics, and how cellular aging research is evolving. Disclaimer: This video contains AI generated educational content. The narration in this video is created using an artificial intelligence voice application and is not a real human voice. #senolytics #longevityscience #cellularaging #aigenerated #glowuphealth

GlowUp Health · 5 min · Source published: 2026-03-11

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…